CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(05): E649-E658
DOI: 10.1055/a-2297-9622
Original article

Adherence to follow-up and resource use after abnormal FIT-screening: Evaluation of the Danish colorectal cancer screening program

1   University Research Clinic for Cancer screening, Randers Regional Hospital, Randers, Denmark (Ringgold ID: RIN53198)
2   Department of Data, Innovation and Research, Lillebaelt Hospital, Vejle, Denmark (Ringgold ID: RIN371420)
,
1   University Research Clinic for Cancer screening, Randers Regional Hospital, Randers, Denmark (Ringgold ID: RIN53198)
3   Department of Clinical Medicine, Aarhus University Faculty of Health Sciences, Aarhus, Denmark (Ringgold ID: RIN53154)
,
Rune Erichsen
4   Department of Clinical Epidemiology, Aarhus University Hospital, Randers, Denmark (Ringgold ID: RIN11297)
5   Department of Surgery, Randers Regional Hospital, Randers, Denmark (Ringgold ID: RIN53198)
,
Berit Andersen
1   University Research Clinic for Cancer screening, Randers Regional Hospital, Randers, Denmark (Ringgold ID: RIN53198)
3   Department of Clinical Medicine, Aarhus University Faculty of Health Sciences, Aarhus, Denmark (Ringgold ID: RIN53154)
,
Matejka Rebolj
6   Centre for Cancer Screening, Prevention, and Early Detection, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom of Great Britain and Northern Ireland (Ringgold ID: RIN4617)
,
Sisse Njor
3   Department of Clinical Medicine, Aarhus University Faculty of Health Sciences, Aarhus, Denmark (Ringgold ID: RIN53154)
1   University Research Clinic for Cancer screening, Randers Regional Hospital, Randers, Denmark (Ringgold ID: RIN53198)
2   Department of Data, Innovation and Research, Lillebaelt Hospital, Vejle, Denmark (Ringgold ID: RIN371420)
› Author Affiliations
Supported by: Einar Willumsen Foundation
Supported by: Aage og Johanne Louis-Hansens Fond J.nr. 20-2B-6191

Abstract

Background and study aims The effectiveness of colorectal cancer screening programs depends on adherence to surveillance protocols for screening-positive individuals. We evaluated adherence in the Danish population-based screening program and estimated the volume of diagnostic resources required to achieve this adherence.

Patients and methods In this register- and population-based study, we included individuals with a positive fecal immunochemical test (FIT) screening from 2014 to 2017 and followed them until mid-2022. All endoscopic, imaging, and surgical procedures performed at public and private hospitals were identified. Adherence to national protocols was reported in terms of proportions and timeliness. Use of diagnostic and surveillance procedures was estimated during a 4-year post-screening period.

Results Among 82,221 individuals with a positive FIT test, 84% had a baseline colonoscopy within 1 month. After removal of intermediate or high-risk adenomas, 12% and 6%, respectively, did not have any follow-up. Only ~50% had timely surveillance. Approximately 10% to 20%, depending on their referral diagnosis, did not have a second surveillance colonoscopy. In addition, 12% with a negative colonoscopy had a second colonoscopy within 4 years.

Conclusions High adherence to baseline colonoscopy after positive FIT-screening is followed by lower adherence throughout the adenoma surveillance program. Better adherence to the guidelines could potentially improve the effectiveness and efficiency of the screening program.

Supplementary Material



Publication History

Received: 13 July 2023

Accepted after revision: 21 March 2024

Article published online:
03 May 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Larsen MB, Njor S, Ingeholm P. et al. Effectiveness of colorectal cancer screening in detecting earlier-stage disease-a nationwide cohort study in Denmark. Gastroenterology 2018; 155: 99-106
  • 2 Njor SH, Larsen MB, Søborg B. et al. Colorectal cancer mortality after randomized implementation of FIT-based screening – a nationwide cohort study. J Med Screening 2022; 29: 241-248
  • 3 Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev 2018; 39: 7-018
  • 4 Lee JK, Jensen CD, Levin TR. et al. Long-term risk of colorectal cancer and related death after adenoma removal in a large, community-based population. Gastroenterology 2020; 158: 884-894.e885
  • 5 Ferlay J EM, Lam F, Colombet M et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2020. https://gco.iarc.fr/today.
  • 6 Ringgaard A. Kræftscreening sætter midtjyske hospitaler under pres. Dagens Medicin; 2015
  • 7 Gessl I, Waldmann E, Britto-Arias M. et al. Surveillance colonoscopy in Austria: Are we following the guidelines?. Endoscopy 2018; 50: 119-127
  • 8 van Heijningen EM, Lansdorp-Vogelaar I, Steyerberg EW. et al. Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study. Gut 2015; 64: 1584-1592
  • 9 Djinbachian R, Dubé AJ, Durand M. et al. Adherence to post-polypectomy surveillance guidelines: a systematic review and meta-analysis. Endoscopy 2019; 51: 673-683
  • 10 Kruse GR, Khan SM, Zaslavsky AM. et al. Overuse of colonoscopy for colorectal cancer screening and surveillance. J Gen Internal Med 2015; 30: 277-283
  • 11 Schoen RE, Pinsky PF, Weissfeld JL. et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology 2010; 138: 73-81
  • 12 Murphy CC, Sandler RS, Grubber JM. et al. Underuse and overuse of colonoscopy for repeat screening and surveillance in the Veterans Health Administration. Clin Gastroenterol Hepatol 2016; 14: 436-444.e431
  • 13 Sundhedsstyrelsen. Anbefalinger vedrørende screening for tyk- & endetarmskræft 2012 [Recommendations regarding colo-rectal cancer screening 2012]. 2012. Contract No.: Report.
  • 14 Atkin WS, Valori R, Kuipers EJ. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Colonoscopic surveillance following adenoma removal. Endoscopy 2012; 44: Se151-163
  • 15 Tarmkræftscreeningsdatabase SfD. Årsrapport 2019. Dansk Tarmkræftscreeningsdatabase. RKKP; 2021.
  • 16 Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-45
  • 17 Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health 2011; 39: 72-74
  • 18 Schmidt M, Schmidt SAJ, Sandegaard JL. et al. The Danish National Patient Registry: a review of content, data quality, and research potential.(Report). Clin Epidemiol 2015; 7: 449
  • 19 Sahl Andersen J, De Fine Olivarius N, Krasnik A. The Danish National Health Service Register. Scand J Public Health 2011; 39: 34-37
  • 20 Danish Pathology Association. Screenings – og adenomkontrolprogram for colorectal cancer [in Danish]: Danish Pathology Association; 2014. https://danskpatologi.org/wp-content/uploads/2016/02/Screenings-og-adenomkontrol-program-tyk-og-endtarmskr%C3%A6ft.pdf.
  • 21 Klabunde CN, Zheng Y, Quinn VP. et al. Influence of age and comorbidity on colorectal cancer screening in the elderly. Am J Prevent Med 2016; 51: e67-e75
  • 22 Thomsen MK, Rasmussen M, Njor SH. et al. Demographic and comorbidity predictors of adherence to diagnostic colonoscopy in the Danish Colorectal Cancer Screening Program: a nationwide cross-sectional study. (ORIGINAL RESEARCH). Clin Epidemiol 2018; 10: 1733
  • 23 Juul FE, Garborg K, Nesbakken E. et al. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials. Gut 2023; 72: 951-957
  • 24 Toes-Zoutendijk E, van Leerdam ME, Dekker E. et al. Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels. Gastroenterology 2017; 152: 767-775.e762
  • 25 Binefa G, Garcia M, Milà N. et al. Colorectal cancer screening programme in Spain: Results of key performance indicators after five rounds (2000–2012). Scientific Rep 2016; 6: 19532
  • 26 Gingold-Belfer R, Leibovitzh H, Boltin D. et al. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis. United Europ Gastroenterol J 2019; 7: 424-448
  • 27 Doubeni CA, Fedewa SA, Levin TR. et al. Modifiable failures in the colorectal cancer screening process and their association with risk of death. Gastroenterology 2019; 156: 63-74.e66
  • 28 Chubak J, McLerran D, Zheng Y. et al. Receipt of colonoscopy following diagnosis of advanced adenomas: an analysis within integrated healthcare delivery systems. Cancer Epidemiol Biomarkers Prev 2019; 28: 91-98
  • 29 Gauci C, Lendzion R, Phan-Thien K-C. et al. Patient compliance with surveillance colonoscopy: patient factors and the use of a graded recall system. ANZ Journal of Surgery 2018; 88: 311-315
  • 30 Bülow Therkildsen S, Larsen PT, Njor S. Subsequent participation in organized FIT based screening following screen-derived colonoscopy – A Danish nationwide cohort study. Prev Med Rep 2023; 32: 102125
  • 31 Clark GR, Fraser CG, Strachan JA. et al. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme. J Med Screening 2022; 29: 249-254
  • 32 Larsen MB, Njor SH, Jensen TM. et al. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme. Scand J Gastroenterol 2019; 54: 1008-1014
  • 33 Cross AJ, Robbins EC, Pack K. et al. Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut 2020; 69: 1645-1658
  • 34 Anderson JC, Baron JA, Ahnen DJ. et al. Factors associated with shorter colonoscopy surveillance intervals for patients with low-risk colorectal adenomas and effects on outcome. Gastroenterology 2017; 152: 1933-1943.e1935
  • 35 Hassan C, Antonelli G, Dumonceau JM. et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020. Endoscopy 2020; 52: 687-700